Contáctenos
De lunes a viernes, de 8 a.m. a 5 p.m.
Our Multidisciplinary Approach
Boston Medical Center (BMC) is an international referral center for the diagnosis and treatment of amyloidosis, a rare group of diseases caused by the abnormal accumulation of the protein amyloid in various parts of the body. Esto puede ocurrir como parte de un trastorno de células plasmáticas (AL) de la médula ósea, como una forma hereditaria (FA), una forma relacionada con la edad (amiloidosis sistémica senil debido a ATTR) o secundaria a enfermedades inflamatorias o infecciosas crónicas (AA).
In conjunction with the Boston University Chobanian & Avedisian School of Medicine, the Amyloidosis Center at BMC offers a multidisciplinary approach to diagnosis and treatment of this multi-organ disorder. Under the direction of Vaishali Sanchorawala, MD, the Center is unique in its approach, providing exceptional care for patients with all forms of systemic and localized amyloidosis through the support of laboratory and clinical research.
Because the disease frequently involves more than one organ system, BMC offers a multispecialty evaluation for patients. This three-day outpatient evaluation is comprised of tests and consultations that help determine the amyloid type and organ system involvement. Los pacientes son guiados a través de cada paso de la evaluación, con médicos y enfermeras que explican por qué se está realizando cada prueba y qué significan los resultados. Una vez que se completa la evaluación, se desarrolla un plan de tratamiento.
Specialists in hematology-oncology, cardiovascular medicine, gastroenterology, kidney (renal) medicine, neurology, otolaryngology, pathology and laboratory medicine, pulmonary medicine, radiation oncology, and urology coordinate to evaluate patients and develop care plans.
Los servicios de consulta médica y patológica también están disponibles para pacientes y médicos.
Please visit BU’s Amyloidosis Center website for more information about the different types of amyloidosis, the patient evaluation process, and consultation services.
Nuestro equipo
The BMC amyloidosis clinical team is a multidisciplinary group of physicians. Cada subespecialista es un experto en amiloide y ha visto a cientos de pacientes con amiloidosis.
Vaishali Sanchorawala, MD
John L. Berk, MD
Sonia Ananthakrishnan, MD
Eric J. Burks, MD
Margaux Dockerty Martin, NP
Sophia (Sophie) Z. Grimes, MSN, RN, FNP-C
Andrea I. Havasi, MD
Shabatun J. Islam, MD
Kwan Hon Vincent Lau, MD
Caryn A. Libbey, MD
Hanni Menn-Josephy, MD
Frederick L. Ruberg, MD
Omar K. Siddiqi, MD
J. Mark Sloan, MD
Resumen investigativo
Los pacientes con amiloidosis han recibido una ayuda inconmensurable gracias a los avances derivados de los programas de investigación traslacional y de laboratorio coordinados por los investigadores clínicos del BMC y los investigadores de laboratorio de la Boston University Chobanian & Avedisian School of Medicine. The Amyloidosis Center at the Boston University Chobanian & Avedisian School of Medicine has been in existence since 1960, and has been responsible for many advances in the field, including some of the first randomized treatment trials, stem-cell transplant trials, trials with novel agents and small molecules, and protocols for liver and heart transplantation for selected patients.